nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS7—Doxorubicin—muscle cancer	0.202	0.312	CbGbCtD
Metformin—NDUFS2—Doxorubicin—muscle cancer	0.202	0.312	CbGbCtD
Metformin—NDUFS3—Doxorubicin—muscle cancer	0.202	0.312	CbGbCtD
Metformin—SLC22A3—Vincristine—muscle cancer	0.0402	0.0623	CbGbCtD
Metformin—NDUFA2—Podofilox—Etoposide—muscle cancer	0.00369	1	CbGdCrCtD
Metformin—NDUFS6—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFA13—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFV2—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFA6—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFB6—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—ND4L—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—ND2—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFA3—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFB9—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFA2—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFB1—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFC1—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFS1—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFB5—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFS5—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFAB1—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFB2—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFA4—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFB7—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—ND3—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFA8—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFV1—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00155	0.0133	CbGpPWpGaD
Metformin—NDUFV3—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00138	0.0119	CbGpPWpGaD
Metformin—NDUFS2—p73 transcription factor network—TP73—muscle cancer	0.00137	0.0118	CbGpPWpGaD
Metformin—NDUFS2—p73 transcription factor network—TP63—muscle cancer	0.00118	0.0102	CbGpPWpGaD
Metformin—NDUFS7—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00117	0.0101	CbGpPWpGaD
Metformin—NDUFS3—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00117	0.0101	CbGpPWpGaD
Metformin—NDUFC2—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00117	0.0101	CbGpPWpGaD
Metformin—NDUFS2—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.0011	0.0095	CbGpPWpGaD
Metformin—NDUFS2—p73 transcription factor network—WT1—muscle cancer	0.00104	0.00897	CbGpPWpGaD
Metformin—PRKAB1—Membrane Trafficking—ASPSCR1—muscle cancer	0.000881	0.0076	CbGpPWpGaD
Metformin—ND1—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.000755	0.00651	CbGpPWpGaD
Metformin—NDUFAF2—cardiac atrium—muscle cancer	0.000616	0.00349	CbGeAlD
Metformin—NDUFB3—cardiac atrium—muscle cancer	0.000616	0.00349	CbGeAlD
Metformin—NDUFA4—renal system—muscle cancer	0.000616	0.00349	CbGeAlD
Metformin—NDUFV1—renal system—muscle cancer	0.000612	0.00346	CbGeAlD
Metformin—NDUFB11—renal system—muscle cancer	0.000612	0.00346	CbGeAlD
Metformin—NDUFA4L2—vagina—muscle cancer	0.000612	0.00346	CbGeAlD
Metformin—NDUFS5—renal system—muscle cancer	0.000609	0.00344	CbGeAlD
Metformin—NDUFB8—renal system—muscle cancer	0.000609	0.00344	CbGeAlD
Metformin—NDUFA9—head—muscle cancer	0.000608	0.00344	CbGeAlD
Metformin—NDUFA13—head—muscle cancer	0.000608	0.00344	CbGeAlD
Metformin—NDUFA11—cardiac atrium—muscle cancer	0.000602	0.00341	CbGeAlD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—FOXO4—muscle cancer	0.000601	0.00518	CbGpPWpGaD
Metformin—ND3—bone marrow—muscle cancer	0.0006	0.0034	CbGeAlD
Metformin—ND2—bone marrow—muscle cancer	0.0006	0.0034	CbGeAlD
Metformin—ND5—bone marrow—muscle cancer	0.0006	0.0034	CbGeAlD
Metformin—ND4L—bone marrow—muscle cancer	0.0006	0.0034	CbGeAlD
Metformin—NDUFA1—head—muscle cancer	0.000598	0.00339	CbGeAlD
Metformin—NDUFB6—cardiac atrium—muscle cancer	0.000598	0.00338	CbGeAlD
Metformin—NDUFAF4—cardiac atrium—muscle cancer	0.000598	0.00338	CbGeAlD
Metformin—NDUFS1—cardiac atrium—muscle cancer	0.000593	0.00336	CbGeAlD
Metformin—PRKAB1—Direct p53 effectors—PMS2—muscle cancer	0.000591	0.00509	CbGpPWpGaD
Metformin—NDUFB10—cardiac atrium—muscle cancer	0.000589	0.00333	CbGeAlD
Metformin—NDUFA2—tendon—muscle cancer	0.000587	0.00332	CbGeAlD
Metformin—NDUFA9—testis—muscle cancer	0.000587	0.00332	CbGeAlD
Metformin—NDUFA13—testis—muscle cancer	0.000587	0.00332	CbGeAlD
Metformin—NDUFB7—cardiac atrium—muscle cancer	0.000585	0.00331	CbGeAlD
Metformin—NDUFA12—cardiac atrium—muscle cancer	0.000585	0.00331	CbGeAlD
Metformin—NDUFS8—cardiac atrium—muscle cancer	0.000581	0.00329	CbGeAlD
Metformin—NDUFB1—cardiac atrium—muscle cancer	0.000581	0.00329	CbGeAlD
Metformin—ND4—bone marrow—muscle cancer	0.000581	0.00329	CbGeAlD
Metformin—NDUFV2—head—muscle cancer	0.000581	0.00329	CbGeAlD
Metformin—NDUFB5—cardiac atrium—muscle cancer	0.000573	0.00324	CbGeAlD
Metformin—NDUFA6—cardiac atrium—muscle cancer	0.000573	0.00324	CbGeAlD
Metformin—NDUFS7—renal system—muscle cancer	0.00057	0.00323	CbGeAlD
Metformin—NDUFS4—cardiac atrium—muscle cancer	0.000569	0.00322	CbGeAlD
Metformin—NDUFA2—bone marrow—muscle cancer	0.000569	0.00322	CbGeAlD
Metformin—NDUFB4—cardiac atrium—muscle cancer	0.000562	0.00318	CbGeAlD
Metformin—NDUFV2—testis—muscle cancer	0.000561	0.00317	CbGeAlD
Metformin—NDUFA10—tendon—muscle cancer	0.00056	0.00317	CbGeAlD
Metformin—NDUFAB1—cardiac atrium—muscle cancer	0.000558	0.00316	CbGeAlD
Metformin—NDUFAF2—Validated targets of C-MYC transcriptional activation—TP53—muscle cancer	0.000556	0.00479	CbGpPWpGaD
Metformin—NDUFC1—tendon—muscle cancer	0.000555	0.00314	CbGeAlD
Metformin—NDUFA8—cardiac atrium—muscle cancer	0.000555	0.00314	CbGeAlD
Metformin—NDUFB9—cardiac atrium—muscle cancer	0.000555	0.00314	CbGeAlD
Metformin—NDUFA4—cardiac atrium—muscle cancer	0.000552	0.00312	CbGeAlD
Metformin—NDUFB2—tendon—muscle cancer	0.000551	0.00312	CbGeAlD
Metformin—PRKAB1—Direct p53 effectors—TP73—muscle cancer	0.000549	0.00474	CbGpPWpGaD
Metformin—NDUFV1—cardiac atrium—muscle cancer	0.000548	0.0031	CbGeAlD
Metformin—NDUFB11—cardiac atrium—muscle cancer	0.000548	0.0031	CbGeAlD
Metformin—NDUFAF1—tendon—muscle cancer	0.000546	0.00309	CbGeAlD
Metformin—NDUFA4L2—testis—muscle cancer	0.000546	0.00309	CbGeAlD
Metformin—NDUFA2—vagina—muscle cancer	0.000545	0.00308	CbGeAlD
Metformin—NDUFS5—cardiac atrium—muscle cancer	0.000545	0.00308	CbGeAlD
Metformin—NDUFB8—cardiac atrium—muscle cancer	0.000545	0.00308	CbGeAlD
Metformin—NDUFA10—bone marrow—muscle cancer	0.000543	0.00307	CbGeAlD
Metformin—NDUFC1—bone marrow—muscle cancer	0.000538	0.00304	CbGeAlD
Metformin—NDUFB3—tendon—muscle cancer	0.000537	0.00304	CbGeAlD
Metformin—NDUFAF2—tendon—muscle cancer	0.000537	0.00304	CbGeAlD
Metformin—NDUFB2—bone marrow—muscle cancer	0.000533	0.00302	CbGeAlD
Metformin—ND3—head—muscle cancer	0.000531	0.00301	CbGeAlD
Metformin—ND2—head—muscle cancer	0.000531	0.00301	CbGeAlD
Metformin—ND4L—head—muscle cancer	0.000531	0.00301	CbGeAlD
Metformin—ND5—head—muscle cancer	0.000531	0.00301	CbGeAlD
Metformin—NDUFAF1—bone marrow—muscle cancer	0.000529	0.00299	CbGeAlD
Metformin—NDUFA11—tendon—muscle cancer	0.000525	0.00297	CbGeAlD
Metformin—ND6—bone marrow—muscle cancer	0.000525	0.00297	CbGeAlD
Metformin—PRKAB1—renal system—muscle cancer	0.000522	0.00295	CbGeAlD
Metformin—NDUFAF4—tendon—muscle cancer	0.000521	0.00295	CbGeAlD
Metformin—NDUFB6—tendon—muscle cancer	0.000521	0.00295	CbGeAlD
Metformin—NDUFAF2—bone marrow—muscle cancer	0.00052	0.00294	CbGeAlD
Metformin—NDUFB3—bone marrow—muscle cancer	0.00052	0.00294	CbGeAlD
Metformin—NDUFS1—tendon—muscle cancer	0.000517	0.00293	CbGeAlD
Metformin—NDUFC1—vagina—muscle cancer	0.000515	0.00292	CbGeAlD
Metformin—ND4—head—muscle cancer	0.000514	0.00291	CbGeAlD
Metformin—NDUFB10—tendon—muscle cancer	0.000513	0.00291	CbGeAlD
Metformin—ND3—testis—muscle cancer	0.000513	0.0029	CbGeAlD
Metformin—ND2—testis—muscle cancer	0.000513	0.0029	CbGeAlD
Metformin—ND5—testis—muscle cancer	0.000513	0.0029	CbGeAlD
Metformin—ND4L—testis—muscle cancer	0.000513	0.0029	CbGeAlD
Metformin—NDUFB2—vagina—muscle cancer	0.000511	0.00289	CbGeAlD
Metformin—NDUFS7—cardiac atrium—muscle cancer	0.000511	0.00289	CbGeAlD
Metformin—NDUFA12—tendon—muscle cancer	0.00051	0.00289	CbGeAlD
Metformin—NDUFB7—tendon—muscle cancer	0.00051	0.00289	CbGeAlD
Metformin—NDUFA5—bone marrow—muscle cancer	0.000508	0.00288	CbGeAlD
Metformin—NDUFAF1—vagina—muscle cancer	0.000507	0.00287	CbGeAlD
Metformin—NDUFS8—tendon—muscle cancer	0.000506	0.00287	CbGeAlD
Metformin—NDUFB1—tendon—muscle cancer	0.000506	0.00287	CbGeAlD
Metformin—NDUFB6—bone marrow—muscle cancer	0.000505	0.00286	CbGeAlD
Metformin—NDUFAF4—bone marrow—muscle cancer	0.000505	0.00286	CbGeAlD
Metformin—NDUFS1—bone marrow—muscle cancer	0.000501	0.00283	CbGeAlD
Metformin—NDUFB5—tendon—muscle cancer	0.000499	0.00283	CbGeAlD
Metformin—NDUFA6—tendon—muscle cancer	0.000499	0.00283	CbGeAlD
Metformin—NDUFAF2—vagina—muscle cancer	0.000499	0.00282	CbGeAlD
Metformin—NDUFB3—vagina—muscle cancer	0.000499	0.00282	CbGeAlD
Metformin—NDUFB10—bone marrow—muscle cancer	0.000497	0.00281	CbGeAlD
Metformin—ND4—testis—muscle cancer	0.000496	0.00281	CbGeAlD
Metformin—NDUFS4—tendon—muscle cancer	0.000496	0.00281	CbGeAlD
Metformin—NDUFA12—bone marrow—muscle cancer	0.000494	0.00279	CbGeAlD
Metformin—NDUFB7—bone marrow—muscle cancer	0.000494	0.00279	CbGeAlD
Metformin—NDUFC2—renal system—muscle cancer	0.000492	0.00278	CbGeAlD
Metformin—NDUFS2—smooth muscle tissue—muscle cancer	0.000491	0.00278	CbGeAlD
Metformin—NDUFB1—bone marrow—muscle cancer	0.00049	0.00278	CbGeAlD
Metformin—NDUFS8—bone marrow—muscle cancer	0.00049	0.00278	CbGeAlD
Metformin—NDUFB4—tendon—muscle cancer	0.00049	0.00277	CbGeAlD
Metformin—NDUFA5—vagina—muscle cancer	0.000487	0.00276	CbGeAlD
Metformin—NDUFA11—vagina—muscle cancer	0.000487	0.00276	CbGeAlD
Metformin—NDUFAB1—tendon—muscle cancer	0.000487	0.00275	CbGeAlD
Metformin—NDUFA2—testis—muscle cancer	0.000486	0.00275	CbGeAlD
Metformin—NDUFS3—smooth muscle tissue—muscle cancer	0.000485	0.00274	CbGeAlD
Metformin—NDUFB5—bone marrow—muscle cancer	0.000484	0.00274	CbGeAlD
Metformin—NDUFA6—bone marrow—muscle cancer	0.000484	0.00274	CbGeAlD
Metformin—NDUFB9—tendon—muscle cancer	0.000484	0.00274	CbGeAlD
Metformin—NDUFA8—tendon—muscle cancer	0.000484	0.00274	CbGeAlD
Metformin—NDUFAF4—vagina—muscle cancer	0.000483	0.00274	CbGeAlD
Metformin—NDUFB6—vagina—muscle cancer	0.000483	0.00274	CbGeAlD
Metformin—NDUFA4—tendon—muscle cancer	0.000481	0.00272	CbGeAlD
Metformin—NDUFS4—bone marrow—muscle cancer	0.000481	0.00272	CbGeAlD
Metformin—NDUFA10—head—muscle cancer	0.00048	0.00272	CbGeAlD
Metformin—NDUFV1—tendon—muscle cancer	0.000478	0.0027	CbGeAlD
Metformin—NDUFB11—tendon—muscle cancer	0.000478	0.0027	CbGeAlD
Metformin—NDUFB10—vagina—muscle cancer	0.000476	0.0027	CbGeAlD
Metformin—NDUFC1—head—muscle cancer	0.000476	0.00269	CbGeAlD
Metformin—NDUFB8—tendon—muscle cancer	0.000475	0.00269	CbGeAlD
Metformin—NDUFS5—tendon—muscle cancer	0.000475	0.00269	CbGeAlD
Metformin—NDUFB4—bone marrow—muscle cancer	0.000474	0.00268	CbGeAlD
Metformin—NDUFA12—vagina—muscle cancer	0.000473	0.00268	CbGeAlD
Metformin—NDUFB7—vagina—muscle cancer	0.000473	0.00268	CbGeAlD
Metformin—NDUFS2—renal system—muscle cancer	0.000473	0.00267	CbGeAlD
Metformin—PRKAB1—Direct p53 effectors—TP63—muscle cancer	0.000472	0.00407	CbGpPWpGaD
Metformin—NDUFB2—head—muscle cancer	0.000472	0.00267	CbGeAlD
Metformin—NDUFAB1—bone marrow—muscle cancer	0.000471	0.00267	CbGeAlD
Metformin—NDUFB1—vagina—muscle cancer	0.00047	0.00266	CbGeAlD
Metformin—NDUFS8—vagina—muscle cancer	0.00047	0.00266	CbGeAlD
Metformin—NDUFB9—bone marrow—muscle cancer	0.000469	0.00265	CbGeAlD
Metformin—NDUFA8—bone marrow—muscle cancer	0.000469	0.00265	CbGeAlD
Metformin—NDUFAF1—head—muscle cancer	0.000468	0.00265	CbGeAlD
Metformin—NDUFS3—renal system—muscle cancer	0.000467	0.00264	CbGeAlD
Metformin—NDUFA4—bone marrow—muscle cancer	0.000466	0.00264	CbGeAlD
Metformin—ND6—head—muscle cancer	0.000464	0.00263	CbGeAlD
Metformin—NDUFA10—testis—muscle cancer	0.000464	0.00263	CbGeAlD
Metformin—NDUFB5—vagina—muscle cancer	0.000463	0.00262	CbGeAlD
Metformin—NDUFA6—vagina—muscle cancer	0.000463	0.00262	CbGeAlD
Metformin—NDUFB11—bone marrow—muscle cancer	0.000463	0.00262	CbGeAlD
Metformin—NDUFV1—bone marrow—muscle cancer	0.000463	0.00262	CbGeAlD
Metformin—NDUFAF2—head—muscle cancer	0.000461	0.00261	CbGeAlD
Metformin—NDUFS4—vagina—muscle cancer	0.00046	0.00261	CbGeAlD
Metformin—NDUFB8—bone marrow—muscle cancer	0.00046	0.0026	CbGeAlD
Metformin—NDUFS5—bone marrow—muscle cancer	0.00046	0.0026	CbGeAlD
Metformin—NDUFC1—testis—muscle cancer	0.00046	0.0026	CbGeAlD
Metformin—NDUFB2—testis—muscle cancer	0.000456	0.00258	CbGeAlD
Metformin—NDUFB4—vagina—muscle cancer	0.000455	0.00257	CbGeAlD
Metformin—NDUFAF1—testis—muscle cancer	0.000452	0.00256	CbGeAlD
Metformin—NDUFAB1—vagina—muscle cancer	0.000452	0.00256	CbGeAlD
Metformin—NDUFA11—head—muscle cancer	0.00045	0.00255	CbGeAlD
Metformin—NDUFA5—head—muscle cancer	0.00045	0.00255	CbGeAlD
Metformin—NDUFA8—vagina—muscle cancer	0.000449	0.00254	CbGeAlD
Metformin—NDUFB9—vagina—muscle cancer	0.000449	0.00254	CbGeAlD
Metformin—ND6—testis—muscle cancer	0.000448	0.00254	CbGeAlD
Metformin—NDUFAF4—head—muscle cancer	0.000447	0.00253	CbGeAlD
Metformin—NDUFB6—head—muscle cancer	0.000447	0.00253	CbGeAlD
Metformin—NDUFA4—vagina—muscle cancer	0.000446	0.00252	CbGeAlD
Metformin—NDUFS7—tendon—muscle cancer	0.000445	0.00252	CbGeAlD
Metformin—NDUFAF2—testis—muscle cancer	0.000445	0.00252	CbGeAlD
Metformin—NDUFB3—testis—muscle cancer	0.000445	0.00252	CbGeAlD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—FOXO1—muscle cancer	0.000444	0.00383	CbGpPWpGaD
Metformin—NDUFV1—vagina—muscle cancer	0.000443	0.00251	CbGeAlD
Metformin—NDUFB11—vagina—muscle cancer	0.000443	0.00251	CbGeAlD
Metformin—NDUFS1—head—muscle cancer	0.000443	0.00251	CbGeAlD
Metformin—Dehydration—Vincristine—muscle cancer	0.000442	0.00755	CcSEcCtD
Metformin—NDUFS5—vagina—muscle cancer	0.000441	0.00249	CbGeAlD
Metformin—NDUFB8—vagina—muscle cancer	0.000441	0.00249	CbGeAlD
Metformin—NDUFC2—cardiac atrium—muscle cancer	0.00044	0.00249	CbGeAlD
Metformin—NDUFB10—head—muscle cancer	0.00044	0.00249	CbGeAlD
Metformin—NDUFA12—head—muscle cancer	0.000437	0.00247	CbGeAlD
Metformin—NDUFB7—head—muscle cancer	0.000437	0.00247	CbGeAlD
Metformin—NDUFA5—testis—muscle cancer	0.000435	0.00246	CbGeAlD
Metformin—NDUFA11—testis—muscle cancer	0.000435	0.00246	CbGeAlD
Metformin—NDUFB1—head—muscle cancer	0.000434	0.00246	CbGeAlD
Metformin—NDUFS8—head—muscle cancer	0.000434	0.00246	CbGeAlD
Metformin—NDUFAF4—testis—muscle cancer	0.000431	0.00244	CbGeAlD
Metformin—NDUFB6—testis—muscle cancer	0.000431	0.00244	CbGeAlD
Metformin—NDUFS7—bone marrow—muscle cancer	0.000431	0.00244	CbGeAlD
Metformin—Neutropenia—Dactinomycin—muscle cancer	0.00043	0.00735	CcSEcCtD
Metformin—NDUFS1—testis—muscle cancer	0.000428	0.00242	CbGeAlD
Metformin—NDUFB5—head—muscle cancer	0.000428	0.00242	CbGeAlD
Metformin—NDUFA6—head—muscle cancer	0.000428	0.00242	CbGeAlD
Metformin—NDUFS4—head—muscle cancer	0.000425	0.00241	CbGeAlD
Metformin—NDUFB10—testis—muscle cancer	0.000425	0.00241	CbGeAlD
Metformin—Nail disorder—Doxorubicin—muscle cancer	0.000425	0.00725	CcSEcCtD
Metformin—NDUFS2—cardiac atrium—muscle cancer	0.000423	0.00239	CbGeAlD
Metformin—NDUFB7—testis—muscle cancer	0.000422	0.00239	CbGeAlD
Metformin—NDUFA12—testis—muscle cancer	0.000422	0.00239	CbGeAlD
Metformin—NDUFB4—head—muscle cancer	0.00042	0.00238	CbGeAlD
Metformin—NDUFB1—testis—muscle cancer	0.000419	0.00237	CbGeAlD
Metformin—NDUFS8—testis—muscle cancer	0.000419	0.00237	CbGeAlD
Metformin—NDUFS3—cardiac atrium—muscle cancer	0.000418	0.00237	CbGeAlD
Metformin—NDUFAB1—head—muscle cancer	0.000417	0.00236	CbGeAlD
Metformin—NDUFB9—head—muscle cancer	0.000415	0.00235	CbGeAlD
Metformin—NDUFA8—head—muscle cancer	0.000415	0.00235	CbGeAlD
Metformin—NDUFB5—testis—muscle cancer	0.000414	0.00234	CbGeAlD
Metformin—NDUFA6—testis—muscle cancer	0.000414	0.00234	CbGeAlD
Metformin—NDUFS7—vagina—muscle cancer	0.000413	0.00234	CbGeAlD
Metformin—NDUFA4—head—muscle cancer	0.000412	0.00233	CbGeAlD
Metformin—Fungal infection—Methotrexate—muscle cancer	0.000412	0.00703	CcSEcCtD
Metformin—NDUFS4—testis—muscle cancer	0.000411	0.00232	CbGeAlD
Metformin—NDUFB11—head—muscle cancer	0.00041	0.00232	CbGeAlD
Metformin—NDUFV1—head—muscle cancer	0.00041	0.00232	CbGeAlD
Metformin—NDUFS5—head—muscle cancer	0.000407	0.0023	CbGeAlD
Metformin—NDUFB8—head—muscle cancer	0.000407	0.0023	CbGeAlD
Metformin—PRKAB1—tendon—muscle cancer	0.000407	0.0023	CbGeAlD
Metformin—NDUFB4—testis—muscle cancer	0.000406	0.0023	CbGeAlD
Metformin—NDUFAB1—testis—muscle cancer	0.000403	0.00228	CbGeAlD
Metformin—ND1—smooth muscle tissue—muscle cancer	0.000403	0.00228	CbGeAlD
Metformin—NDUFA8—testis—muscle cancer	0.000401	0.00227	CbGeAlD
Metformin—NDUFB9—testis—muscle cancer	0.000401	0.00227	CbGeAlD
Metformin—NDUFA4—testis—muscle cancer	0.000398	0.00225	CbGeAlD
Metformin—NDUFB11—testis—muscle cancer	0.000396	0.00224	CbGeAlD
Metformin—NDUFV1—testis—muscle cancer	0.000396	0.00224	CbGeAlD
Metformin—PRKAB1—bone marrow—muscle cancer	0.000394	0.00223	CbGeAlD
Metformin—NDUFB8—testis—muscle cancer	0.000393	0.00223	CbGeAlD
Metformin—NDUFS5—testis—muscle cancer	0.000393	0.00223	CbGeAlD
Metformin—ND1—renal system—muscle cancer	0.000388	0.00219	CbGeAlD
Metformin—Neutropenia—Vincristine—muscle cancer	0.000384	0.00657	CcSEcCtD
Metformin—NDUFC2—tendon—muscle cancer	0.000384	0.00217	CbGeAlD
Metformin—NDUFS7—head—muscle cancer	0.000382	0.00216	CbGeAlD
Metformin—PRKAB1—vagina—muscle cancer	0.000378	0.00214	CbGeAlD
Metformin—NDUFC2—bone marrow—muscle cancer	0.000372	0.0021	CbGeAlD
Metformin—NDUFS2—tendon—muscle cancer	0.000369	0.00209	CbGeAlD
Metformin—NDUFS7—testis—muscle cancer	0.000369	0.00209	CbGeAlD
Metformin—Hepatitis—Dactinomycin—muscle cancer	0.000368	0.00629	CcSEcCtD
Metformin—NDUFS3—tendon—muscle cancer	0.000364	0.00206	CbGeAlD
Metformin—Neuropathy peripheral—Vincristine—muscle cancer	0.000359	0.00614	CcSEcCtD
Metformin—NDUFS2—bone marrow—muscle cancer	0.000357	0.00202	CbGeAlD
Metformin—Fungal infection—Doxorubicin—muscle cancer	0.000357	0.00609	CcSEcCtD
Metformin—NDUFC2—vagina—muscle cancer	0.000356	0.00201	CbGeAlD
Metformin—NDUFS3—bone marrow—muscle cancer	0.000353	0.002	CbGeAlD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—IGF2—muscle cancer	0.000351	0.00303	CbGpPWpGaD
Metformin—PRKAB1—head—muscle cancer	0.000349	0.00197	CbGeAlD
Metformin—Cramp muscle—Etoposide—muscle cancer	0.000347	0.00593	CcSEcCtD
Metformin—NDUFS2—vagina—muscle cancer	0.000342	0.00194	CbGeAlD
Metformin—Flushing—Dactinomycin—muscle cancer	0.000342	0.00584	CcSEcCtD
Metformin—PRKAB1—IGF1R signaling cascade—IGF2—muscle cancer	0.000342	0.00295	CbGpPWpGaD
Metformin—NDUFS3—vagina—muscle cancer	0.000338	0.00191	CbGeAlD
Metformin—Rigors—Doxorubicin—muscle cancer	0.000337	0.00576	CcSEcCtD
Metformin—PRKAB1—testis—muscle cancer	0.000337	0.00191	CbGeAlD
Metformin—NDUFS2—p73 transcription factor network—MDM2—muscle cancer	0.000337	0.00291	CbGpPWpGaD
Metformin—Chills—Dactinomycin—muscle cancer	0.000331	0.00564	CcSEcCtD
Metformin—Blood disorder—Doxorubicin—muscle cancer	0.00033	0.00563	CcSEcCtD
Metformin—NDUFC2—head—muscle cancer	0.000329	0.00186	CbGeAlD
Metformin—Hypoaesthesia—Vincristine—muscle cancer	0.000327	0.00559	CcSEcCtD
Metformin—Sweating increased—Etoposide—muscle cancer	0.000324	0.00554	CcSEcCtD
Metformin—Connective tissue disorder—Vincristine—muscle cancer	0.000323	0.00552	CcSEcCtD
Metformin—Erythema—Dactinomycin—muscle cancer	0.000321	0.00548	CcSEcCtD
Metformin—NDUFC2—testis—muscle cancer	0.000318	0.0018	CbGeAlD
Metformin—NDUFS2—head—muscle cancer	0.000316	0.00179	CbGeAlD
Metformin—NDUFS3—head—muscle cancer	0.000312	0.00177	CbGeAlD
Metformin—Neutropenia—Etoposide—muscle cancer	0.000311	0.00532	CcSEcCtD
Metformin—SLC22A2—renal system—muscle cancer	0.000311	0.00176	CbGeAlD
Metformin—Cardiac disorder—Vincristine—muscle cancer	0.000305	0.00522	CcSEcCtD
Metformin—NDUFS2—testis—muscle cancer	0.000305	0.00173	CbGeAlD
Metformin—NDUFS3—testis—muscle cancer	0.000302	0.00171	CbGeAlD
Metformin—Angiopathy—Vincristine—muscle cancer	0.000299	0.0051	CcSEcCtD
Metformin—Ill-defined disorder—Dactinomycin—muscle cancer	0.000298	0.00508	CcSEcCtD
Metformin—Infestation—Etoposide—muscle cancer	0.000297	0.00507	CcSEcCtD
Metformin—Infestation NOS—Etoposide—muscle cancer	0.000297	0.00507	CcSEcCtD
Metformin—Mediastinal disorder—Vincristine—muscle cancer	0.000297	0.00506	CcSEcCtD
Metformin—ND1—bone marrow—muscle cancer	0.000293	0.00166	CbGeAlD
Metformin—Neuropathy peripheral—Etoposide—muscle cancer	0.000291	0.00497	CcSEcCtD
Metformin—Malaise—Dactinomycin—muscle cancer	0.000289	0.00494	CcSEcCtD
Metformin—Hepatobiliary disease—Etoposide—muscle cancer	0.000281	0.0048	CcSEcCtD
Metformin—SLC22A3—embryo—muscle cancer	0.000277	0.00157	CbGeAlD
Metformin—NDUFB11—Metabolism—FH—muscle cancer	0.000274	0.00237	CbGpPWpGaD
Metformin—Myalgia—Dactinomycin—muscle cancer	0.000273	0.00466	CcSEcCtD
Metformin—Discomfort—Dactinomycin—muscle cancer	0.00027	0.00461	CcSEcCtD
Metformin—Hypoaesthesia—Etoposide—muscle cancer	0.000265	0.00453	CcSEcCtD
Metformin—SLC47A1—renal system—muscle cancer	0.000263	0.00149	CbGeAlD
Metformin—Oedema—Dactinomycin—muscle cancer	0.000262	0.00447	CcSEcCtD
Metformin—Infection—Dactinomycin—muscle cancer	0.00026	0.00444	CcSEcCtD
Metformin—ND1—head—muscle cancer	0.000259	0.00147	CbGeAlD
Metformin—Neuropathy—Doxorubicin—muscle cancer	0.000259	0.00441	CcSEcCtD
Metformin—Thrombocytopenia—Dactinomycin—muscle cancer	0.000256	0.00438	CcSEcCtD
Metformin—NDUFA11—Metabolism—FH—muscle cancer	0.000251	0.00216	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—FH—muscle cancer	0.000251	0.00216	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—FH—muscle cancer	0.000251	0.00216	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—FH—muscle cancer	0.000251	0.00216	CbGpPWpGaD
Metformin—ND1—testis—muscle cancer	0.000251	0.00142	CbGeAlD
Metformin—Anorexia—Dactinomycin—muscle cancer	0.000249	0.00426	CcSEcCtD
Metformin—Eye disorder—Etoposide—muscle cancer	0.000249	0.00425	CcSEcCtD
Metformin—Flushing—Etoposide—muscle cancer	0.000247	0.00422	CcSEcCtD
Metformin—Cardiac disorder—Etoposide—muscle cancer	0.000247	0.00422	CcSEcCtD
Metformin—Hypertension—Vincristine—muscle cancer	0.000247	0.00422	CcSEcCtD
Metformin—Myalgia—Vincristine—muscle cancer	0.000244	0.00416	CcSEcCtD
Metformin—Angiopathy—Etoposide—muscle cancer	0.000242	0.00413	CcSEcCtD
Metformin—Immune system disorder—Etoposide—muscle cancer	0.000241	0.00411	CcSEcCtD
Metformin—Mediastinal disorder—Etoposide—muscle cancer	0.00024	0.0041	CcSEcCtD
Metformin—Chills—Etoposide—muscle cancer	0.000239	0.00408	CcSEcCtD
Metformin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000238	0.00407	CcSEcCtD
Metformin—Lethargy—Methotrexate—muscle cancer	0.000236	0.00402	CcSEcCtD
Metformin—Oedema—Vincristine—muscle cancer	0.000234	0.00399	CcSEcCtD
Metformin—ND2—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—ND4L—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—ND5—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—ND3—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—ND4—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—ND6—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—FH—muscle cancer	0.000233	0.00201	CbGpPWpGaD
Metformin—Infection—Vincristine—muscle cancer	0.000232	0.00397	CcSEcCtD
Metformin—Nervous system disorder—Vincristine—muscle cancer	0.000229	0.00392	CcSEcCtD
Metformin—Thrombocytopenia—Vincristine—muscle cancer	0.000229	0.00391	CcSEcCtD
Metformin—Decreased appetite—Dactinomycin—muscle cancer	0.000228	0.00388	CcSEcCtD
Metformin—Dysgeusia—Etoposide—muscle cancer	0.000227	0.00388	CcSEcCtD
Metformin—Hyperhidrosis—Vincristine—muscle cancer	0.000226	0.00386	CcSEcCtD
Metformin—Fatigue—Dactinomycin—muscle cancer	0.000226	0.00385	CcSEcCtD
Metformin—Muscle spasms—Etoposide—muscle cancer	0.000223	0.00381	CcSEcCtD
Metformin—Anorexia—Vincristine—muscle cancer	0.000223	0.00381	CcSEcCtD
Metformin—SLC22A1—renal system—muscle cancer	0.00022	0.00124	CbGeAlD
Metformin—Hypotension—Vincristine—muscle cancer	0.000218	0.00373	CcSEcCtD
Metformin—SLC22A3—smooth muscle tissue—muscle cancer	0.000218	0.00123	CbGeAlD
Metformin—Feeling abnormal—Dactinomycin—muscle cancer	0.000216	0.00368	CcSEcCtD
Metformin—Ill-defined disorder—Etoposide—muscle cancer	0.000215	0.00368	CcSEcCtD
Metformin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000214	0.00365	CcSEcCtD
Metformin—Liver function test abnormal—Methotrexate—muscle cancer	0.000213	0.00364	CcSEcCtD
Metformin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000213	0.00364	CcSEcCtD
Metformin—Renal impairment—Doxorubicin—muscle cancer	0.00021	0.00359	CcSEcCtD
Metformin—SLC22A3—renal system—muscle cancer	0.00021	0.00119	CbGeAlD
Metformin—Paraesthesia—Vincristine—muscle cancer	0.00021	0.00359	CcSEcCtD
Metformin—Malaise—Etoposide—muscle cancer	0.000209	0.00357	CcSEcCtD
Metformin—Breast disorder—Methotrexate—muscle cancer	0.000209	0.00356	CcSEcCtD
Metformin—NDUFV3—Metabolism—FH—muscle cancer	0.000208	0.00179	CbGpPWpGaD
Metformin—Abdominal pain—Dactinomycin—muscle cancer	0.000207	0.00353	CcSEcCtD
Metformin—SLC47A1—tendon—muscle cancer	0.000206	0.00116	CbGeAlD
Metformin—Hypoglycaemia—Doxorubicin—muscle cancer	0.000205	0.0035	CcSEcCtD
Metformin—Loss of consciousness—Etoposide—muscle cancer	0.000204	0.00348	CcSEcCtD
Metformin—Lethargy—Doxorubicin—muscle cancer	0.000204	0.00348	CcSEcCtD
Metformin—Decreased appetite—Vincristine—muscle cancer	0.000203	0.00347	CcSEcCtD
Metformin—Gastrointestinal disorder—Vincristine—muscle cancer	0.000202	0.00345	CcSEcCtD
Metformin—Fatigue—Vincristine—muscle cancer	0.000202	0.00344	CcSEcCtD
Metformin—Hypertension—Etoposide—muscle cancer	0.0002	0.00342	CcSEcCtD
Metformin—Constipation—Vincristine—muscle cancer	0.0002	0.00341	CcSEcCtD
Metformin—Pain in extremity—Doxorubicin—muscle cancer	0.0002	0.00341	CcSEcCtD
Metformin—Chest pain—Etoposide—muscle cancer	0.000198	0.00337	CcSEcCtD
Metformin—Migraine—Doxorubicin—muscle cancer	0.000197	0.00336	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000196	0.00335	CcSEcCtD
Metformin—Pancreatitis—Methotrexate—muscle cancer	0.000196	0.00334	CcSEcCtD
Metformin—Discomfort—Etoposide—muscle cancer	0.000195	0.00333	CcSEcCtD
Metformin—Abdominal discomfort—Methotrexate—muscle cancer	0.000191	0.00327	CcSEcCtD
Metformin—Gastrointestinal pain—Vincristine—muscle cancer	0.000191	0.00326	CcSEcCtD
Metformin—SLC47A1—vagina—muscle cancer	0.000191	0.00108	CbGeAlD
Metformin—Infection—Etoposide—muscle cancer	0.000188	0.00321	CcSEcCtD
Metformin—Asthenia—Dactinomycin—muscle cancer	0.000188	0.00321	CcSEcCtD
Metformin—Neutropenia—Methotrexate—muscle cancer	0.000187	0.00319	CcSEcCtD
Metformin—Dehydration—Doxorubicin—muscle cancer	0.000186	0.00317	CcSEcCtD
Metformin—Thrombocytopenia—Etoposide—muscle cancer	0.000185	0.00317	CcSEcCtD
Metformin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000185	0.00317	CcSEcCtD
Metformin—Abdominal pain—Vincristine—muscle cancer	0.000185	0.00316	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—muscle cancer	0.000185	0.00315	CcSEcCtD
Metformin—Skin disorder—Etoposide—muscle cancer	0.000184	0.00314	CcSEcCtD
Metformin—Hyperhidrosis—Etoposide—muscle cancer	0.000183	0.00313	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—muscle cancer	0.000183	0.00312	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—muscle cancer	0.000181	0.00308	CcSEcCtD
Metformin—Anorexia—Etoposide—muscle cancer	0.000181	0.00308	CcSEcCtD
Metformin—Diarrhoea—Dactinomycin—muscle cancer	0.000179	0.00306	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—muscle cancer	0.000179	0.00305	CcSEcCtD
Metformin—Infestation—Methotrexate—muscle cancer	0.000178	0.00304	CcSEcCtD
Metformin—Infestation NOS—Methotrexate—muscle cancer	0.000178	0.00304	CcSEcCtD
Metformin—Drowsiness—Methotrexate—muscle cancer	0.000178	0.00304	CcSEcCtD
Metformin—Hypotension—Etoposide—muscle cancer	0.000177	0.00302	CcSEcCtD
Metformin—NDUFS3—Metabolism—FH—muscle cancer	0.000177	0.00152	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—FH—muscle cancer	0.000177	0.00152	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—FH—muscle cancer	0.000177	0.00152	CbGpPWpGaD
Metformin—SLC47A1—head—muscle cancer	0.000176	0.000997	CbGeAlD
Metformin—Abdominal distension—Doxorubicin—muscle cancer	0.000174	0.00297	CcSEcCtD
Metformin—Influenza—Doxorubicin—muscle cancer	0.000173	0.00295	CcSEcCtD
Metformin—SLC47A1—testis—muscle cancer	0.00017	0.000963	CbGeAlD
Metformin—Paraesthesia—Etoposide—muscle cancer	0.00017	0.0029	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—muscle cancer	0.000169	0.00289	CcSEcCtD
Metformin—Dyspnoea—Etoposide—muscle cancer	0.000169	0.00288	CcSEcCtD
Metformin—Somnolence—Etoposide—muscle cancer	0.000168	0.00288	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—muscle cancer	0.000168	0.00287	CcSEcCtD
Metformin—Hepatobiliary disease—Methotrexate—muscle cancer	0.000168	0.00287	CcSEcCtD
Metformin—Asthenia—Vincristine—muscle cancer	0.000168	0.00286	CcSEcCtD
Metformin—Vomiting—Dactinomycin—muscle cancer	0.000166	0.00284	CcSEcCtD
Metformin—NDUFS2—Metabolism—FH—muscle cancer	0.000166	0.00143	CbGpPWpGaD
Metformin—Rash—Dactinomycin—muscle cancer	0.000165	0.00282	CcSEcCtD
Metformin—Decreased appetite—Etoposide—muscle cancer	0.000165	0.00281	CcSEcCtD
Metformin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000164	0.00279	CcSEcCtD
Metformin—Fatigue—Etoposide—muscle cancer	0.000163	0.00279	CcSEcCtD
Metformin—Constipation—Etoposide—muscle cancer	0.000162	0.00277	CcSEcCtD
Metformin—Neutropenia—Doxorubicin—muscle cancer	0.000162	0.00276	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000161	0.00274	CcSEcCtD
Metformin—Diarrhoea—Vincristine—muscle cancer	0.00016	0.00273	CcSEcCtD
Metformin—Hepatitis—Methotrexate—muscle cancer	0.00016	0.00273	CcSEcCtD
Metformin—SLC22A1—vagina—muscle cancer	0.000159	0.000901	CbGeAlD
Metformin—Feeling abnormal—Etoposide—muscle cancer	0.000156	0.00267	CcSEcCtD
Metformin—Nausea—Dactinomycin—muscle cancer	0.000155	0.00265	CcSEcCtD
Metformin—NDUFB11—Metabolism—MED12—muscle cancer	0.000155	0.00134	CbGpPWpGaD
Metformin—Gastrointestinal pain—Etoposide—muscle cancer	0.000155	0.00264	CcSEcCtD
Metformin—Dizziness—Vincristine—muscle cancer	0.000155	0.00264	CcSEcCtD
Metformin—Infestation—Doxorubicin—muscle cancer	0.000154	0.00263	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—muscle cancer	0.000154	0.00263	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—muscle cancer	0.000154	0.00263	CcSEcCtD
Metformin—SLC22A3—vagina—muscle cancer	0.000152	0.000861	CbGeAlD
Metformin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000151	0.00258	CcSEcCtD
Metformin—Urticaria—Etoposide—muscle cancer	0.00015	0.00257	CcSEcCtD
Metformin—Abdominal pain—Etoposide—muscle cancer	0.00015	0.00256	CcSEcCtD
Metformin—Eye disorder—Methotrexate—muscle cancer	0.000149	0.00255	CcSEcCtD
Metformin—Vomiting—Vincristine—muscle cancer	0.000149	0.00254	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—muscle cancer	0.000148	0.00253	CcSEcCtD
Metformin—Rash—Vincristine—muscle cancer	0.000147	0.00252	CcSEcCtD
Metformin—Dermatitis—Vincristine—muscle cancer	0.000147	0.00252	CcSEcCtD
Metformin—SLC22A1—head—muscle cancer	0.000147	0.000832	CbGeAlD
Metformin—Headache—Vincristine—muscle cancer	0.000146	0.0025	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000146	0.00249	CcSEcCtD
Metformin—Angiopathy—Methotrexate—muscle cancer	0.000145	0.00247	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—muscle cancer	0.000144	0.00246	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—muscle cancer	0.000144	0.00246	CcSEcCtD
Metformin—Chills—Methotrexate—muscle cancer	0.000143	0.00245	CcSEcCtD
Metformin—NDUFA12—Metabolism—MED12—muscle cancer	0.000142	0.00122	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—MED12—muscle cancer	0.000142	0.00122	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—MED12—muscle cancer	0.000142	0.00122	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—MED12—muscle cancer	0.000142	0.00122	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—ENO2—muscle cancer	0.000141	0.00122	CbGpPWpGaD
Metformin—Bradycardia—Doxorubicin—muscle cancer	0.000141	0.0024	CcSEcCtD
Metformin—SLC22A3—head—muscle cancer	0.000141	0.000795	CbGeAlD
Metformin—Erythema—Methotrexate—muscle cancer	0.000139	0.00237	CcSEcCtD
Metformin—Malnutrition—Methotrexate—muscle cancer	0.000139	0.00237	CcSEcCtD
Metformin—Nausea—Vincristine—muscle cancer	0.000139	0.00237	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—muscle cancer	0.000139	0.00237	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—muscle cancer	0.000138	0.00236	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—muscle cancer	0.000138	0.00235	CcSEcCtD
Metformin—PRKAB1—AMPK Signaling—TP53—muscle cancer	0.000136	0.00118	CbGpPWpGaD
Metformin—Oedema peripheral—Doxorubicin—muscle cancer	0.000136	0.00233	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—muscle cancer	0.000136	0.00232	CcSEcCtD
Metformin—Asthenia—Etoposide—muscle cancer	0.000136	0.00232	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—muscle cancer	0.000136	0.00232	CcSEcCtD
Metformin—SLC22A3—testis—muscle cancer	0.000136	0.000768	CbGeAlD
Metformin—PRKAB1—Direct p53 effectors—MDM2—muscle cancer	0.000135	0.00116	CbGpPWpGaD
Metformin—Pruritus—Etoposide—muscle cancer	0.000134	0.00229	CcSEcCtD
Metformin—ND4—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—ND2—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—ND4L—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—ND3—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—ND5—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—ND6—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—MED12—muscle cancer	0.000132	0.00114	CbGpPWpGaD
Metformin—Vision blurred—Methotrexate—muscle cancer	0.000131	0.00224	CcSEcCtD
Metformin—Diarrhoea—Etoposide—muscle cancer	0.00013	0.00221	CcSEcCtD
Metformin—NDUFA11—Metabolism—ENO2—muscle cancer	0.000129	0.00111	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—ENO2—muscle cancer	0.000129	0.00111	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—ENO2—muscle cancer	0.000129	0.00111	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—ENO2—muscle cancer	0.000129	0.00111	CbGpPWpGaD
Metformin—Eye disorder—Doxorubicin—muscle cancer	0.000129	0.00221	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—muscle cancer	0.000129	0.0022	CcSEcCtD
Metformin—Flushing—Doxorubicin—muscle cancer	0.000128	0.00219	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—muscle cancer	0.000128	0.00219	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—muscle cancer	0.000125	0.00214	CcSEcCtD
Metformin—Malaise—Methotrexate—muscle cancer	0.000125	0.00214	CcSEcCtD
Metformin—Dizziness—Etoposide—muscle cancer	0.000125	0.00214	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—muscle cancer	0.000125	0.00213	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—muscle cancer	0.000125	0.00213	CcSEcCtD
Metformin—Chills—Doxorubicin—muscle cancer	0.000124	0.00212	CcSEcCtD
Metformin—Vomiting—Etoposide—muscle cancer	0.00012	0.00206	CcSEcCtD
Metformin—Erythema—Doxorubicin—muscle cancer	0.00012	0.00206	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—muscle cancer	0.00012	0.00206	CcSEcCtD
Metformin—NDUFS8—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—ND5—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—ND4L—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—ND3—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—ND6—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—ND4—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—ND2—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—ENO2—muscle cancer	0.00012	0.00104	CbGpPWpGaD
Metformin—Rash—Etoposide—muscle cancer	0.000119	0.00204	CcSEcCtD
Metformin—Dermatitis—Etoposide—muscle cancer	0.000119	0.00204	CcSEcCtD
Metformin—Headache—Etoposide—muscle cancer	0.000119	0.00203	CcSEcCtD
Metformin—Flatulence—Doxorubicin—muscle cancer	0.000119	0.00203	CcSEcCtD
Metformin—Chest pain—Methotrexate—muscle cancer	0.000118	0.00202	CcSEcCtD
Metformin—Myalgia—Methotrexate—muscle cancer	0.000118	0.00202	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—muscle cancer	0.000118	0.00201	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000118	0.00201	CcSEcCtD
Metformin—NDUFV3—Metabolism—MED12—muscle cancer	0.000117	0.00101	CbGpPWpGaD
Metformin—Discomfort—Methotrexate—muscle cancer	0.000117	0.002	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—muscle cancer	0.000116	0.00198	CcSEcCtD
Metformin—ND1—Metabolism—FH—muscle cancer	0.000114	0.000982	CbGpPWpGaD
Metformin—Vision blurred—Doxorubicin—muscle cancer	0.000113	0.00194	CcSEcCtD
Metformin—Infection—Methotrexate—muscle cancer	0.000113	0.00192	CcSEcCtD
Metformin—Nausea—Etoposide—muscle cancer	0.000113	0.00192	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—muscle cancer	0.000112	0.00191	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—muscle cancer	0.000111	0.0019	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—muscle cancer	0.000111	0.0019	CcSEcCtD
Metformin—Skin disorder—Methotrexate—muscle cancer	0.00011	0.00188	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—muscle cancer	0.00011	0.00187	CcSEcCtD
Metformin—PRKAB1—Signaling Pathways—KIDINS220—muscle cancer	0.000109	0.00094	CbGpPWpGaD
Metformin—Malaise—Doxorubicin—muscle cancer	0.000109	0.00185	CcSEcCtD
Metformin—Anorexia—Methotrexate—muscle cancer	0.000108	0.00185	CcSEcCtD
Metformin—Syncope—Doxorubicin—muscle cancer	0.000108	0.00184	CcSEcCtD
Metformin—NDUFV3—Metabolism—ENO2—muscle cancer	0.000107	0.000924	CbGpPWpGaD
Metformin—Palpitations—Doxorubicin—muscle cancer	0.000106	0.00182	CcSEcCtD
Metformin—Hypotension—Methotrexate—muscle cancer	0.000106	0.00181	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—muscle cancer	0.000106	0.00181	CcSEcCtD
Metformin—Hypertension—Doxorubicin—muscle cancer	0.000104	0.00177	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000103	0.00177	CcSEcCtD
Metformin—Myalgia—Doxorubicin—muscle cancer	0.000102	0.00175	CcSEcCtD
Metformin—Chest pain—Doxorubicin—muscle cancer	0.000102	0.00175	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—muscle cancer	0.000102	0.00174	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000102	0.00174	CcSEcCtD
Metformin—Discomfort—Doxorubicin—muscle cancer	0.000101	0.00173	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—muscle cancer	0.000101	0.00173	CcSEcCtD
Metformin—Somnolence—Methotrexate—muscle cancer	0.000101	0.00172	CcSEcCtD
Metformin—NDUFC2—Metabolism—MED12—muscle cancer	9.99e-05	0.000861	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—MED12—muscle cancer	9.99e-05	0.000861	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—MED12—muscle cancer	9.99e-05	0.000861	CbGpPWpGaD
Metformin—Dyspepsia—Methotrexate—muscle cancer	9.99e-05	0.00171	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—muscle cancer	9.86e-05	0.00168	CcSEcCtD
Metformin—Oedema—Doxorubicin—muscle cancer	9.82e-05	0.00168	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—muscle cancer	9.8e-05	0.00167	CcSEcCtD
Metformin—Fatigue—Methotrexate—muscle cancer	9.78e-05	0.00167	CcSEcCtD
Metformin—Infection—Doxorubicin—muscle cancer	9.76e-05	0.00167	CcSEcCtD
Metformin—Shock—Doxorubicin—muscle cancer	9.67e-05	0.00165	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—muscle cancer	9.63e-05	0.00165	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—muscle cancer	9.62e-05	0.00164	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—muscle cancer	9.54e-05	0.00163	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—muscle cancer	9.5e-05	0.00162	CcSEcCtD
Metformin—NDUFS2—Metabolism—MED12—muscle cancer	9.39e-05	0.00081	CbGpPWpGaD
Metformin—Anorexia—Doxorubicin—muscle cancer	9.36e-05	0.0016	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—muscle cancer	9.35e-05	0.0016	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—muscle cancer	9.28e-05	0.00158	CcSEcCtD
Metformin—Hypotension—Doxorubicin—muscle cancer	9.18e-05	0.00157	CcSEcCtD
Metformin—NDUFC2—Metabolism—ENO2—muscle cancer	9.11e-05	0.000785	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—ENO2—muscle cancer	9.11e-05	0.000785	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—ENO2—muscle cancer	9.11e-05	0.000785	CbGpPWpGaD
Metformin—Urticaria—Methotrexate—muscle cancer	9.01e-05	0.00154	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—muscle cancer	8.97e-05	0.00153	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	8.95e-05	0.00153	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—muscle cancer	8.82e-05	0.00151	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—muscle cancer	8.76e-05	0.0015	CcSEcCtD
Metformin—Somnolence—Doxorubicin—muscle cancer	8.73e-05	0.00149	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—muscle cancer	8.65e-05	0.00148	CcSEcCtD
Metformin—NDUFS2—Metabolism—ENO2—muscle cancer	8.56e-05	0.000738	CbGpPWpGaD
Metformin—Decreased appetite—Doxorubicin—muscle cancer	8.54e-05	0.00146	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—muscle cancer	8.48e-05	0.00145	CcSEcCtD
Metformin—Fatigue—Doxorubicin—muscle cancer	8.47e-05	0.00145	CcSEcCtD
Metformin—Constipation—Doxorubicin—muscle cancer	8.4e-05	0.00143	CcSEcCtD
Metformin—Asthenia—Methotrexate—muscle cancer	8.14e-05	0.00139	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—muscle cancer	8.1e-05	0.00138	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—muscle cancer	8.03e-05	0.00137	CcSEcCtD
Metformin—Pruritus—Methotrexate—muscle cancer	8.03e-05	0.00137	CcSEcCtD
Metformin—Urticaria—Doxorubicin—muscle cancer	7.8e-05	0.00133	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—muscle cancer	7.77e-05	0.00133	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—muscle cancer	7.76e-05	0.00133	CcSEcCtD
Metformin—PRKAB1—Direct p53 effectors—TP53—muscle cancer	7.74e-05	0.000667	CbGpPWpGaD
Metformin—Dizziness—Methotrexate—muscle cancer	7.5e-05	0.00128	CcSEcCtD
Metformin—Vomiting—Methotrexate—muscle cancer	7.21e-05	0.00123	CcSEcCtD
Metformin—Rash—Methotrexate—muscle cancer	7.15e-05	0.00122	CcSEcCtD
Metformin—Dermatitis—Methotrexate—muscle cancer	7.15e-05	0.00122	CcSEcCtD
Metformin—Headache—Methotrexate—muscle cancer	7.11e-05	0.00121	CcSEcCtD
Metformin—Asthenia—Doxorubicin—muscle cancer	7.05e-05	0.0012	CcSEcCtD
Metformin—Pruritus—Doxorubicin—muscle cancer	6.95e-05	0.00119	CcSEcCtD
Metformin—Nausea—Methotrexate—muscle cancer	6.74e-05	0.00115	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—muscle cancer	6.72e-05	0.00115	CcSEcCtD
Metformin—Dizziness—Doxorubicin—muscle cancer	6.5e-05	0.00111	CcSEcCtD
Metformin—ND1—Metabolism—MED12—muscle cancer	6.44e-05	0.000555	CbGpPWpGaD
Metformin—Vomiting—Doxorubicin—muscle cancer	6.25e-05	0.00107	CcSEcCtD
Metformin—Rash—Doxorubicin—muscle cancer	6.19e-05	0.00106	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—muscle cancer	6.19e-05	0.00106	CcSEcCtD
Metformin—Headache—Doxorubicin—muscle cancer	6.15e-05	0.00105	CcSEcCtD
Metformin—ND1—Metabolism—ENO2—muscle cancer	5.87e-05	0.000506	CbGpPWpGaD
Metformin—Nausea—Doxorubicin—muscle cancer	5.84e-05	0.000996	CcSEcCtD
Metformin—SLC22A3—Metabolism—FH—muscle cancer	5.31e-05	0.000458	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PTGS2—muscle cancer	4.92e-05	0.000424	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PTGS2—muscle cancer	4.5e-05	0.000388	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTGS2—muscle cancer	4.5e-05	0.000388	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PTGS2—muscle cancer	4.5e-05	0.000388	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PTGS2—muscle cancer	4.5e-05	0.000388	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTCH1—muscle cancer	4.29e-05	0.00037	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—ND3—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—ND5—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—ND4—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—ND2—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—ND6—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000361	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—muscle cancer	3.73e-05	0.000322	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FOXO4—muscle cancer	3.69e-05	0.000318	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CNR1—muscle cancer	3.62e-05	0.000312	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—FH—muscle cancer	3.33e-05	0.000287	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—MDM2—muscle cancer	3.21e-05	0.000277	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—muscle cancer	3.17e-05	0.000274	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—muscle cancer	3.17e-05	0.000274	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—muscle cancer	3.17e-05	0.000274	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—FH—muscle cancer	3.1e-05	0.000268	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MED12—muscle cancer	3e-05	0.000259	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—MDM2—muscle cancer	2.99e-05	0.000258	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—muscle cancer	2.98e-05	0.000257	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF2—muscle cancer	2.96e-05	0.000255	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ENO2—muscle cancer	2.73e-05	0.000236	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FOXO1—muscle cancer	2.73e-05	0.000235	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MDM2—muscle cancer	2.46e-05	0.000212	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MDM2—muscle cancer	2.29e-05	0.000198	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KIT—muscle cancer	2.08e-05	0.000179	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—muscle cancer	2.04e-05	0.000176	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MED12—muscle cancer	1.88e-05	0.000162	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MED12—muscle cancer	1.75e-05	0.000151	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO2—muscle cancer	1.71e-05	0.000148	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MDM2—muscle cancer	1.64e-05	0.000141	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO2—muscle cancer	1.6e-05	0.000138	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—muscle cancer	1.24e-05	0.000107	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—muscle cancer	9.52e-06	8.21e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—muscle cancer	9.39e-06	8.09e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—muscle cancer	5.97e-06	5.15e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—muscle cancer	5.57e-06	4.8e-05	CbGpPWpGaD
